Rhumbline Advisers lowered its holdings in Veeva Systems Inc. (NYSE:VEEV – Free Report) by 4.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 203,693 shares of the technology company’s stock after selling 10,366 shares during the quarter. Rhumbline Advisers’ holdings in Veeva Systems were worth $60,682,000 at the end of the most recent quarter.
A number of other hedge funds and other institutional investors have also bought and sold shares of VEEV. GPS Wealth Strategies Group LLC lifted its stake in shares of Veeva Systems by 196.4% in the third quarter. GPS Wealth Strategies Group LLC now owns 83 shares of the technology company’s stock valued at $25,000 after buying an additional 55 shares in the last quarter. OLD Second National Bank of Aurora bought a new stake in shares of Veeva Systems during the third quarter worth about $30,000. Legacy Investment Solutions LLC acquired a new stake in shares of Veeva Systems in the 2nd quarter worth about $32,000. Cary Street Partners Investment Advisory LLC lifted its position in Veeva Systems by 58.3% in the 2nd quarter. Cary Street Partners Investment Advisory LLC now owns 133 shares of the technology company’s stock valued at $38,000 after acquiring an additional 49 shares in the last quarter. Finally, Elevation Point Wealth Partners LLC purchased a new stake in shares of Veeva Systems in the second quarter worth approximately $41,000. Institutional investors own 88.20% of the company’s stock.
Insiders Place Their Bets
In other Veeva Systems news, insider Thomas D. Schwenger sold 1,000 shares of the firm’s stock in a transaction on Tuesday, January 13th. The stock was sold at an average price of $231.43, for a total value of $231,430.00. Following the completion of the sale, the insider directly owned 23,204 shares of the company’s stock, valued at $5,370,101.72. This trade represents a 4.13% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through this link. Company insiders own 10.30% of the company’s stock.
Analyst Ratings Changes
View Our Latest Stock Analysis on VEEV
Veeva Systems Price Performance
NYSE VEEV opened at $171.99 on Friday. The business’s fifty day moving average is $217.49 and its 200-day moving average is $258.59. The stock has a market capitalization of $28.27 billion, a price-to-earnings ratio of 33.46, a PEG ratio of 1.23 and a beta of 1.08. Veeva Systems Inc. has a one year low of $168.13 and a one year high of $310.50.
Veeva Systems (NYSE:VEEV – Get Free Report) last posted its quarterly earnings results on Thursday, November 20th. The technology company reported $2.04 earnings per share for the quarter, beating the consensus estimate of $1.95 by $0.09. The company had revenue of $0.81 million during the quarter, compared to analyst estimates of $792.37 million. Veeva Systems had a net margin of 27.93% and a return on equity of 13.68%. The firm’s revenue for the quarter was up 16.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.75 earnings per share. Veeva Systems has set its FY 2026 guidance at 7.930-7.93 EPS and its Q4 2026 guidance at 1.920-1.920 EPS. Research analysts expect that Veeva Systems Inc. will post 4.35 EPS for the current fiscal year.
Veeva Systems declared that its board has authorized a stock repurchase program on Monday, January 5th that permits the company to buyback $2.00 billion in shares. This buyback authorization permits the technology company to reacquire up to 5.5% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s board believes its shares are undervalued.
Veeva Systems Profile
Veeva Systems (NYSE: VEEV) is a cloud software company that develops industry-specific applications and data solutions for the global life sciences sector. Founded in 2007 and headquartered in Pleasanton, California, Veeva focuses on helping pharmaceutical, biotechnology, medical device and consumer health companies manage regulated content, clinical and regulatory processes, quality systems, and commercial operations in a compliant, cloud-native environment. The company completed its initial public offering in 2013 and has since expanded its product suite and international footprint.
Veeva’s product portfolio centers on its Vault platform and related application suites, which provide content and data management, clinical trial and regulatory workflows, quality management, and structured commercial capabilities such as customer relationship management and promotional content management.
See Also
- Five stocks we like better than Veeva Systems
- Nvidia CEO Issues Bold Tesla Call
- Your Bank Account Is No Longer Safe
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- New gold price target
Want to see what other hedge funds are holding VEEV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Veeva Systems Inc. (NYSE:VEEV – Free Report).
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
